113 related articles for article (PubMed ID: 9736200)
1. Elevation of serum tumor marker CA 15.3 levels as the first manifestation of metastatic breast cancer to the cavernous sinus.
Chandran R; Lee AG
J Neuroophthalmol; 1998 Sep; 18(3):176-7. PubMed ID: 9736200
[TBL] [Abstract][Full Text] [Related]
2. [Enophthalmos caused by orbital metastasis of breast carcinoma].
Lagrèze WD; Wesendahl TA; Kommerell G
Klin Monbl Augenheilkd; 1997 Jul; 211(1):68-9. PubMed ID: 9340411
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of serum HER2 and CA 15-3 at the time of diagnosis of metastatic breast cancer.
Fehm T; Jäger W; Krämer S; Sohn C; Solomayer E; Wallwiener D; Gebauer G
Anticancer Res; 2004; 24(3b):1987-92. PubMed ID: 15274389
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients.
Tampellini M; Berruti A; Bitossi R; Gorzegno G; Alabiso I; Bottini A; Farris A; Donadio M; Sarobba MG; Manzin E; Durando A; Defabiani E; De Matteis A; Ardine M; Castiglione F; Danese S; Bertone E; Alabiso O; Massobrio M; Dogliotti L
Breast Cancer Res Treat; 2006 Aug; 98(3):241-8. PubMed ID: 16670941
[TBL] [Abstract][Full Text] [Related]
5. [Prevalence of elevated serum CA 15-3 at time of metastatic relapse of breast cancer and correlation with hormone receptor status].
Bensouda Y; André F; Boulet T; Al-Ghuzlan A; Conforti R; Troalen F; Bourgier C; Errihani H; Spielmann M; Delaloge S
Bull Cancer; 2009 Oct; 96(10):923-8. PubMed ID: 19696005
[TBL] [Abstract][Full Text] [Related]
6. Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results.
Tserkezoglou A; Kontou S; Hadjieleftheriou G; Apostolikas N; Vassilomanolakis M; Sikiotis K; Salamalekis E; Tseke P; Magiakos G
Anticancer Res; 2006; 26(3B):2339-44. PubMed ID: 16821613
[TBL] [Abstract][Full Text] [Related]
7. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of metastatic carcinoma to the cavernous sinus by computed tomograpy-guided fine-needle aspiration.
Lin A; Foroozan R; Carrier D; Yen MT
Am J Ophthalmol; 2004 Nov; 138(5):864-6. PubMed ID: 15531326
[TBL] [Abstract][Full Text] [Related]
9. Bilateral orbital metastases from breast cancer: a case report of successful palliation using stereotactic radiotherapy.
Kim JH; Choi SY; Cho CK; Yang KM; Noh WC; Kim MS
Breast J; 2011; 17(6):669-71. PubMed ID: 21999613
[TBL] [Abstract][Full Text] [Related]
10. Stage IV primitive-appearing sinus and orbital rhabdomyosarcoma presenting in a 68-year-old female previously treated for breast cancer.
Morris CL; Mukundan S; Heimann A; Cummings TJ; Chesnutt DA
Orbit; 2008; 27(1):73-7. PubMed ID: 18307153
[TBL] [Abstract][Full Text] [Related]
11. The relation between tumor marker Ca 15-3 and metastases in interpectoral lymph nodes in breast cancer patients.
Vrdoljak DV; Knezevic F; Ramljak V
Saudi Med J; 2006 Apr; 27(4):460-2. PubMed ID: 16598320
[TBL] [Abstract][Full Text] [Related]
12. Importance of CEA and CA 15-3 during disease progression in metastatic breast cancer patients.
Laessig D; Nagel D; Heinemann V; Untch M; Kahlert S; Bauerfeind I; Stieber P
Anticancer Res; 2007; 27(4A):1963-8. PubMed ID: 17649806
[TBL] [Abstract][Full Text] [Related]
13. Use of TPS and CA 15-3 assays for monitoring chemotherapy in metastatic breast cancer patients.
Einarsson R; Lindman H; Bergh J
Anticancer Res; 2000; 20(6D):5089-93. PubMed ID: 11326674
[TBL] [Abstract][Full Text] [Related]
14. A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study.
Guadagni F; Ferroni P; Carlini S; Mariotti S; Spila A; Aloe S; D'Alessandro R; Carone MD; Cicchetti A; Ricciotti A; Venturo I; Perri P; Di Filippo F; Cognetti F; Botti C; Roselli M
Clin Cancer Res; 2001 Aug; 7(8):2357-62. PubMed ID: 11489813
[TBL] [Abstract][Full Text] [Related]
15. [Cavernous sinus syndrome: an initial expression of a breast carcinoma].
Martin Polo J; Rivas López T; Martin Polo R; Ortin Castaño A; Arcaya Navarro J; Cacho Gutiérrez J
Neurologia; 2005 Apr; 20(3):153-5. PubMed ID: 15815952
[TBL] [Abstract][Full Text] [Related]
16. [The first case of metastatic tumor of the right orbit in Otolaryngology Department of the Jagiellonian University in Krakow].
Wiatr M; Składzień J
Przegl Lek; 2002; 59(7):551-3. PubMed ID: 12516249
[TBL] [Abstract][Full Text] [Related]
17. [A case of cavernous sinus cavernous hemangioma presenting with cavernous sinus syndrome].
Katada E; Matsukawa N; Maki M; Ojika K
Rinsho Shinkeigaku; 2002 Oct; 42(10):930-4. PubMed ID: 12739381
[TBL] [Abstract][Full Text] [Related]
18. Tolosa-Hunt syndrome due to actinomycosis of the cavernous sinus: the infectious hypothesis revisited.
Mandrioli J; Frank G; Sola P; Leone ME; Guaraldi G; Guaraldi P; Collina G; Roncaroli F; Cortelli P
Headache; 2004 Sep; 44(8):806-11. PubMed ID: 15330828
[TBL] [Abstract][Full Text] [Related]
19. Periodic measurement of serum carcinoembryonic antigen and carbohydrate antigen 15-3 levels as postoperative surveillance after breast cancer surgery.
Nakamura T; Kimura T; Umehara Y; Suzuki K; Okamoto K; Okumura T; Morizumi S; Kawabata T
Surg Today; 2005; 35(1):19-21. PubMed ID: 15622458
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of CEA and CA 15.3 in patients with locoregional breast cancer.
Molina R; Filella X; Alicarte J; Zanon G; Pahisa J; Munoz M; Farrus B; Ballesta AM
Anticancer Res; 2003; 23(2A):1035-41. PubMed ID: 12820344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
